The Discounted Cash Flow (DCF) valuation of Lotus Eye Hospital and Institute Ltd (LOTUSEYE.NS) is 26.65 INR. With the latest stock price at 74.29 INR, the upside of Lotus Eye Hospital and Institute Ltd based on DCF is -64.1%.
Based on the latest price of 74.29 INR and our DCF valuation, Lotus Eye Hospital and Institute Ltd (LOTUSEYE.NS) is a sell. selling LOTUSEYE.NS stocks now will result in a potential gain of 64.1%.
| Range | Selected | |
| WACC / Discount Rate | 10.9% - 13.7% | 12.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 21.23 - 36.54 | 26.65 |
| Upside | -71.4% - -50.8% | -64.1% |